In mid-July 2020, a team of cardiologists and radiation oncologists became the first doctors in WA and the second in Australia to use stereotactic ablative body radiotherapy (SABR) to treat a heart disease patient. The team of Perth doctors carried out the procedure in close collaboration with Washington University of St Louis (WUSTL), where the technology was developed. SABR is a precise, targeted treatment that is most commonly used to treat cancer. It was utilised to treat a patient with ventricular tachycardia (VT). SABR delivers a high dose of precise radiation to kill tumours with minimal exposure to surrounding healthy…
This content is restricted to site members. If you are an existing user, please log in. New users may register below.